Retatrutide Molecular Weight

The figure and its provenance

4,731.33 Da appears across supplier catalogues and reference aggregators, with formula C221H342N46O68. It is consistent enough to be the working figure, and it is what previous versions of these articles stated. What was not stated is that it cannot be checked against a primary chemical database, because no retatrutide entry exists in PubChem under any of its names.

Where the disagreement sits

At least one reference source gives C228H350N48O66 at approximately 4,894.58 Da, a difference of roughly 163 Da, which is far too large to be rounding. Two formulae cannot both describe one molecule. Without a database entry to arbitrate, the discrepancy simply stands, and anyone relying on the mass should know it exists.

Why this matters for calculations

Molarity is mass divided by molecular weight, so a 163 Da uncertainty propagates directly into any molar concentration. It is a smaller error than the ones found elsewhere in this library (TB-500's figure was wrong by 5.6-fold, GHK-Cu's by 15%), but it is an uncertainty rather than a settled number, which is a different kind of problem.

Where the mass comes from structurally

Thirty-nine residues built on a modified GIP scaffold, plus a C20 fatty diacid conjugated through a γGlu-2xOEG linker. The lipid and linker contribute several hundred daltons on top of the peptide backbone, which is why retatrutide is heavier than semaglutide at 4,114 Da despite a comparable residue count.

How to handle the uncertainty

Use whichever figure a certificate of analysis states, and check it by mass spectrometry rather than assuming. Where a supplier's stated mass differs from the commonly quoted 4,731, that is not automatically an error. It may reflect the other reported formula, or a salt form. The absence of an authoritative record means the certificate is the best available reference for a given batch.

Quick reference